Showing results (2531-2540 of 4,401) with videos related to

Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|October 20, 2015
Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI)-Mediated Lipid TransportChris Dockendorff, Patrick W Faloon, Miao Yu, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate CancerAudris Huang, Lata Jayaraman, Aberra Fura, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
A New Highly Reactive and Low Lipophilicity Fluorine-18 Labeled Tetrazine Derivative for Pretargeted PET ImagingOuti Keinänen, Xiang-Guo Li, Naveen K Chenna, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Probabilistic Approach to Generating MPOs and Its Application as a Scoring Function for CNS DrugsHakan Gunaydin
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease InhibitorSanthosh F Neelamkavil, Sony Agrawal, Thomas Bara, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand LibraryMattia Stucchi, Peter Gmeiner, Harald Huebner, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Incentives to Repurpose Existing Drugs for Orphan IndicationsAnnette K Kwok, Fabian M Koenigbauer
ACS Medicinal Chemistry Letters|August 20, 2015
Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease InhibitorsNicolino Pala, Annelies Stevaert, Roberto Dallocchio, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate CancerAaron Balog, Richard Rampulla, Gregory S Martin, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 InhibitorsW Michael Seganish, Thierry O Fischmann, Brad Sherborne, et al.
Pageof 441